MECOM and intrahepatic cholangiocarcinoma: An anti-EVI-1 molecule called pyrrole-imidazole polyamide PIP1 was recently designed which inhibits EVI-1 in vitro, and the study authors suggested PIP1 should be investigated as a possible targeted treatment for EVI-1-positive ICC.